Geode Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311K | Sell |
41,968
-55,725
| -57% | -$412K | ﹤0.01% | 3723 |
|
|
2025
Q1 | $841K | Buy |
97,693
+3
| +0% | +$26 | ﹤0.01% | 3364 |
|
|
2024
Q4 | $3.49M | Buy |
97,690
+1,161
| +1% | +$41.5K | ﹤0.01% | 2917 |
|
|
2024
Q3 | $4.56M | Sell |
96,529
-3,208
| -3% | -$152K | ﹤0.01% | 2810 |
|
|
2024
Q2 | $5.01M | Buy |
99,737
+5,408
| +6% | +$272K | ﹤0.01% | 2721 |
|
|
2024
Q1 | $10.6M | Buy |
94,329
+2,444
| +3% | +$274K | ﹤0.01% | 2293 |
|
|
2023
Q4 | $5.33M | Buy |
91,885
+5,578
| +6% | +$324K | ﹤0.01% | 2673 |
|
|
2023
Q3 | $2.74M | Buy |
86,307
+6,080
| +8% | +$193K | ﹤0.01% | 2952 |
|
|
2023
Q2 | $6.6M | Buy |
80,227
+8,273
| +11% | +$680K | ﹤0.01% | 2544 |
|
|
2023
Q1 | $7.39M | Buy |
71,954
+3,655
| +5% | +$376K | ﹤0.01% | 2444 |
|
|
2022
Q4 | $10M | Buy |
68,299
+2,298
| +3% | +$337K | ﹤0.01% | 2265 |
|
|
2022
Q3 | $11.2M | Buy |
66,001
+3,123
| +5% | +$528K | ﹤0.01% | 2165 |
|
|
2022
Q2 | $7.26M | Buy |
62,878
+16,206
| +35% | +$1.87M | ﹤0.01% | 2469 |
|
|
2022
Q1 | $4.66M | Buy |
46,672
+1,192
| +3% | +$119K | ﹤0.01% | 2834 |
|
|
2021
Q4 | $7.07M | Buy |
45,480
+2,907
| +7% | +$452K | ﹤0.01% | 2682 |
|
|
2021
Q3 | $10M | Buy |
42,573
+496
| +1% | +$117K | ﹤0.01% | 2455 |
|
|
2021
Q2 | $14.3M | Buy |
42,077
+3,755
| +10% | +$1.27M | ﹤0.01% | 2208 |
|
|
2021
Q1 | $15.5M | Buy |
38,322
+3,950
| +11% | +$1.6M | ﹤0.01% | 2038 |
|
|
2020
Q4 | $22.9M | Buy |
34,372
+1,213
| +4% | +$807K | ﹤0.01% | 1638 |
|
|
2020
Q3 | $15.4M | Buy |
33,159
+2,709
| +9% | +$1.26M | ﹤0.01% | 1705 |
|
|
2020
Q2 | $17.8M | Buy |
30,450
+9,258
| +44% | +$5.42M | ﹤0.01% | 1589 |
|
|
2020
Q1 | $3.09M | Buy |
21,192
+25
| +0.1% | +$3.64K | ﹤0.01% | 2431 |
|
|
2019
Q4 | $3.03M | Buy |
21,167
+1,791
| +9% | +$257K | ﹤0.01% | 2757 |
|
|
2019
Q3 | $765K | Buy |
19,376
+47
| +0.2% | +$1.86K | ﹤0.01% | 3329 |
|
|
2019
Q2 | $1.96M | Buy |
19,329
+4,543
| +31% | +$460K | ﹤0.01% | 2966 |
|
|
2019
Q1 | $1.94M | Buy |
14,786
+9,657
| +188% | +$1.27M | ﹤0.01% | 2870 |
|
|
2018
Q4 | $523K | Buy |
5,129
+232
| +5% | +$23.7K | ﹤0.01% | 3361 |
|
|
2018
Q3 | $1.22M | Buy |
4,897
+1,261
| +35% | +$315K | ﹤0.01% | 3129 |
|
|
2018
Q2 | $1.62M | Buy |
3,636
+187
| +5% | +$83.5K | ﹤0.01% | 2978 |
|
|
2018
Q1 | $1.36M | Buy |
3,449
+922
| +36% | +$363K | ﹤0.01% | 2973 |
|
|
2017
Q4 | $1.04M | Buy |
2,527
+233
| +10% | +$95.6K | ﹤0.01% | 3079 |
|
|
2017
Q3 | $991K | Buy |
+2,294
| New | +$991K | ﹤0.01% | 3122 |
|